SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-13-062767
Filing Date
2013-11-18
Accepted
2013-11-18 16:15:28
Documents
6
Period of Report
2013-12-17
Effectiveness Date
2013-11-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A v360720_def14a.htm DEF 14A 685070
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_ibio.jpg GRAPHIC 8856
4 GRAPHIC sig_elizabeth-moyle.jpg GRAPHIC 3436
5 GRAPHIC sig_robert-kay.jpg GRAPHIC 4131
6 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-13-062767.txt   709738
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-35023 | Film No.: 131227188
SIC: 2834 Pharmaceutical Preparations